Table 3.

Contingency tables of combined KRT20, ERBB2 and ESR1 (A), KRT20 (B) and ESR1 (C) cut-offs at transurethral resection before the start of neoadjuvant chemotherapy in relation to pathological complete response (pCR) at cystectomy.

(A)
KRT20 (≥40.485 ΔCt) ERBB2 (≥38.84 ΔCt) ESR1 (≥34.485 ΔCt)	n (%)
	no pCR	pCR
no	16 (84.2)	3 (15.8)	19 (100)
yes	16 (45.7)	19 (54.3)	35 (100)
total	32 (59.3)	22 (40.7)	54 (100)
Fisher’s p = 0.009
(B)
KRT20 ≥ 40.485 ΔCt	n (%)		Total
	no pCR	pCR
no	31 (66)	16 (34)	47 (100
yes	1 (14.3)	6 (85.7)	7 (100)
total	32 (59.3)	22 (40.7)	54 (100)
Fisher’s p = 0.014
(C)
ESR1 ≥ 34.485 ΔCt	n (%)		Total
	no pCR	pCR
no	24 (66.7)	12 (33.3)	36 (100)
yes	8 (44.4)	10 (55.6)	18 (100)
total	32 (59.3)	22 (40.7)	54 (100)
Fisher’s p = 0.148